149 related articles for article (PubMed ID: 7601697)
1. Flexible labeling, streamlined drug approval advocated at workshop.
Raef TA
J Am Vet Med Assoc; 1995 Jul; 207(1):7-9. PubMed ID: 7601697
[No Abstract] [Full Text] [Related]
2. Review of the first interactive workshop on professional flexible labeling. An Animal Health Institute perspective.
Farho CJ
J Am Vet Med Assoc; 1995 Oct; 207(7):869-71. PubMed ID: 7559007
[No Abstract] [Full Text] [Related]
3. Professional drug labeling.
Terry M
J Am Vet Med Assoc; 1993 May; 202(10):1711-2;discussion 1713-7. PubMed ID: 8514591
[No Abstract] [Full Text] [Related]
4. A step closer to reality: professional flexible labeling for animal drugs.
Gloyd JS
J Am Vet Med Assoc; 1996 Feb; 208(4):457-9. PubMed ID: 8603883
[No Abstract] [Full Text] [Related]
5. Review of the first interactive workshop on professional flexible labeling. The Center for Veterinary Medicine perspective.
Sundlof SF
J Am Vet Med Assoc; 1995 Oct; 207(7):867-8. PubMed ID: 7559006
[No Abstract] [Full Text] [Related]
6. Extralabel drug use and compounding in veterinary medicine.
Geyer RE
Food Drug Law J; 1997; 52(3):291-5. PubMed ID: 10343027
[No Abstract] [Full Text] [Related]
7. Implications for the FDA/Center for Veterinary Medicine (CVM).
Geyer RE
J Am Vet Med Assoc; 1993 May; 202(10):1718-23. PubMed ID: 8514592
[No Abstract] [Full Text] [Related]
8. AVMA legislation: partial solution to drug availability problem.
Gloyd JS
J Am Vet Med Assoc; 1993 Apr; 202(7):1055-6. PubMed ID: 8473213
[No Abstract] [Full Text] [Related]
9. Extra-label rules: the final outcome.
Curry-Galvin E
J Am Vet Med Assoc; 1997 Jan; 210(1):10-2. PubMed ID: 8977639
[No Abstract] [Full Text] [Related]
10. Compounding forum: FDA-CVM hears veterinarians' views.
J Am Vet Med Assoc; 1993 Nov; 203(10):1367-72. PubMed ID: 8276690
[No Abstract] [Full Text] [Related]
11. Current FDA policy on use of human-labeled drugs in animals.
Teske RH
J Am Vet Med Assoc; 1993 May; 202(10):1632-3;discussion 1634. PubMed ID: 8514570
[No Abstract] [Full Text] [Related]
12. Extra-label drug use--pharmaceutical industry view.
Welser JR
J Am Vet Med Assoc; 1993 May; 202(10):1635-42;discussion 1654-8. PubMed ID: 8514571
[No Abstract] [Full Text] [Related]
13. Concerned about unlicensed practice.
Allen JM
J Am Vet Med Assoc; 1991 Sep; 199(6):679. PubMed ID: 1955352
[No Abstract] [Full Text] [Related]
14. An overview of current programs on drug development and regulation for small ruminants--pharmaceutical industry perspective.
Terry M
Vet Hum Toxicol; 1993; 35 Suppl 2():12-3. PubMed ID: 8236759
[No Abstract] [Full Text] [Related]
15. Special pesticide formulations. Veterinarians must follow EPA rules.
J Am Vet Med Assoc; 2004 Aug; 225(4):490-1. PubMed ID: 15344349
[No Abstract] [Full Text] [Related]
16. The contribution of clinical pharmacology to new drug approvals.
Brown SA
J Am Vet Med Assoc; 1993 May; 202(10):1700-2;discussion 1713-7. PubMed ID: 8514588
[No Abstract] [Full Text] [Related]
17. [Off-label use and the 'explanation'].
Kamphuis A; de Groot SJ
Tijdschr Diergeneeskd; 2003 May; 128(10):340-1. PubMed ID: 12793041
[No Abstract] [Full Text] [Related]
18. Helpful tips for extralabel drug use: record keeping, record access, and product labels. The FDA-Center for Veterinary Medicine and the American Veterinary Medicine Association.
J Am Vet Med Assoc; 1998 Mar; 212(5):666-7. PubMed ID: 9556375
[No Abstract] [Full Text] [Related]
19. Thoughts on the Schuyler and Algon bulk-drug issue.
Stribling J
J Am Vet Med Assoc; 1988 Oct; 193(8):918-9. PubMed ID: 3192471
[No Abstract] [Full Text] [Related]
20. Scientific basis for nonapproved use of drugs in veterinary practice.
Brumbaugh GW
J Am Vet Med Assoc; 1993 May; 202(10):1693-6;discussion 1713-7. PubMed ID: 8514586
[No Abstract] [Full Text] [Related]
[Next] [New Search]